2R3-29624-46456
3 vaccinations
3 coded responses
19 check-ins
3 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 930 / CA
- Registered
- 2020-12-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Dose 1 — Pfizer-BioNTech
-
2020-12-19
Registered in v-safe
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-27
- 2021-01-03
-
2021-01-08
Dose 2 — Pfizer-BioNTech
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-24
-
2021-01-29
Survey response — day 21, dose 2MedDRA: Infection, Pharyngeal ulceration — Feeling: Good · Be unable to work, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Infected ulcer throat that bledMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-29
Report sent to call center — day 21, dose 2Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-07
- 2021-02-12
- 2021-02-21
- 2021-04-11
-
2021-06-10
Call successfulParticipant prefers to complete VAERS report online
- 2021-07-09
-
2021-11-08
Dose 3 — Pfizer-BioNTech
-
2022-01-10
Survey response — 12 months, dose 2MedDRA: Ageusia, Anosmia, Fatigue, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Loss of taste and smell, severe fatigue, congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-01-10
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-01-11
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-11-08
Survey response — 12 months, dose 3MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-11-08
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-11-09
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-11-08 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-29 | Successful 2021-06-10 |
Participant prefers to complete VAERS report online |
| 2022-01-10 | Successful 2022-01-11 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
| 2022-11-08 | Successful 2022-11-09 |
Participant prefers to complete VAERS report online |
Free text
Release 3 — day 21, dose 2
Symptoms: Infected ulcer throat that bled
Release 10 — 12 months, dose 2
Symptoms: Loss of taste and smell, severe fatigue, congestion
Release 12 — 12 months, dose 3
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Infection | ✓ | ✓ | ✓ |
| SD | Pharyngeal ulceration | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release